The impact of delayed anti-vascular endothelial growth factor treatment for retinal diseases during the COVID-19 lockdown.

Photodiagnosis Photodyn Ther · 2021 · PMC8305215 · PMID 34314862

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

[13] As such, even if CMT is similar in the third year of treatment, there may be significant differences between visual gains.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.